FDA Drug Recalls

Recalls / Class II

Class IID-1623-2020

Product

Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in a) 90-count bottles (NDC 68788-7604-09), b) 100-count tablets (NDC 68788-7604-01), Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc.

Affected lot / code info
a) Lot #: A0220Q, Exp. Date: 10/31/2020; b) Lot #: K15171, Exp. Date: 10/31/2020

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Preferred Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1250 N Lakeview Ave Ste O, N/A, Anaheim, California 92807-1801

Distribution

Quantity
N/A
Distribution pattern
Repackaged tablets sold to three physicians located in CA and GA.

Timeline

Recall initiated
2020-09-02
FDA classified
2020-09-24
Posted by FDA
2020-09-30
Terminated
2024-04-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1623-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls